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SUMMARY
Transport of luminal antigens across the intestinal epithelium
and their encounter with the underlying immune system is
critical for generation of appropriate immunity. This review
describes our current understanding of how macromolecules
trafﬁc the intestine and the subsequent responses.
The gastrointestinal tract performs opposing functions of
nutrient absorption, barrier maintenance, and the delivery
of luminal substances for the appropriate induction of
tolerogenic or protective adaptive immunity. The single-
layer epithelium lining the gastrointestinal tract is cen-
tral to each of these functions by facilitating the uptake and
processing of nutrients, providing a physical and chemical
barrier to potential pathogens, and delivering macromo-
lecular substances to the immune system to initiate
adaptive immune responses. Speciﬁc transport mecha-
nisms allow nutrient uptake and the delivery of macro-
molecules to the immune system while maintaining the
epithelial barrier. This review examines historical obser-
vations supporting macromolecular transport by the in-
testinal epithelium, recent insights into the transport of
luminal macromolecules to promote adaptive immunity,
and how this process is regulated to promote appropriate
immune responses. Understanding how luminal macro-
molecules are delivered to the immune system and how
this is regulated may provide insight into the pathophysi-
ology of inﬂammatory diseases of the gastrointestinal tract
and potential preventative or therapeutic strategies. (Cell
Mol Gastroenterol Hepatol 2019;7:729–737; https://doi.org/
10.1016/j.jcmgh.2019.01.003)
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The primary function of the gastrointestinal tract isthe digestion and absorption of nutrients to provide
for energy and growth. This function necessitates that the
lining of the intestinal tract be semipermeable and envi-
ronmentally exposed. Paradoxically, because of the abun-
dant microbes and potential pathogens within this
environment, this single-layer epithelium also must act as a
physical barrier to protect the host. Furthermore, it has
become appreciated that the immune system underlying
this epithelium is continually exposed to luminal macro-
molecules to allow the appropriate induction of adaptive
immune responses to promote tolerance in the steady state
and protective immunity during infection. How the epithe-
lium lining the gastrointestinal tract performs these appar-
ently opposing tasks is a central question to intestinal
physiology and mucosal immunity, which may be answered
in part by recent observations. This review discusses his-
torical observations suggesting macromolecules cross the
intestinal epithelium, distinctions between the pathways of
nutrient absorption and pathways supporting adaptive im-
munity, the models of transport across the epithelium, and
immune responses toward luminal macromolecules.
Historical Overview of Macromolecular
Transport
Gastrointestinal physiology supports that nutrients, such
as lipids, carbohydrates, and proteins, are ﬁrst digested and
then absorbed as small molecules in the small intestine. For
example, carbohydrates are broken down into mono-
saccharides and transported into enterocytes by speciﬁc
transporters; proteins are digested into free amino acids,
dipeptides, and tripeptides; transported into enterocytes by
speciﬁc transporters; and digested into amino acids for
release; and lipids are digested into monoglycerides and
free fatty acids, which freely diffuse into enterocytes for
reassembly, packaging into chylomicrons, and extrusion on
the basolateral surface. Proteolytic enzymes, serum pro-
teins, glycoproteins, lipids, and mucopolysaccharides
contribute to the array of macromolecules in the gut lumen.
Studies on gastric secretions and duodenal ﬂuids have
indicated that proteins and molecules with appreciable
protein content constitute the major fraction (approxi-
mately 60%) of nondialyzable substances in the gastroin-
testinal tract. The remaining 25%–30% is mainly
carbohydrates with small but undetermined amounts of
lipid and nucleic acids.1,2 In addition, the gut microbial
community contributes to the luminal contents directly
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through the production of microbial products and metabo-
lites (Table 1).
Although digestion and absorption of small molecules
accounts for the vast majority of dietary substances crossing
the epithelium, that this would be the only way in which
dietary substances traverse the epithelium is at odds with
the growing understanding that the immune system un-
derlying the epithelium actively samples the luminal con-
tents throughout life to induce antigen-speciﬁc tolerance to
dietary substances in the steady state. Antigen-speciﬁc
tolerance occurs when intestinal dendritic cells (DCs) ac-
quire luminal substances and migrate to the mesenteric
lymph nodes (MLNs) to stimulate antigen-speciﬁc naive T
cells to promote the generation of forkhead box P3
(Foxp3þ)-induced regulatory T cells (Tregs).3 These newly
committed induced Tregs (iTregs) migrate back to the in-
testine where they undergo secondary expansion by mac-
rophages producing interleukin (IL)104 to suppress
inﬂammatory responses to innocuous substances from the
gut lumen. The differentiation of Tregs from naive T cells
requires stimulation by DCs containing major histocompat-
ibility complex II loaded with cognate antigen. Typically,
DCs acquire proteins and process them into peptides for T-
cell stimulation. The peptides loaded onto major histocom-
patibility complexes are signiﬁcantly larger than the free
amino acids released by enterocytes after digestion.5 Thus,
pathways to deliver luminal macromolecules to DCs un-
derlying the epithelium to induce adaptive immunity must
exist, however, the pathways of macromolecular transport
supporting this process have been controversial.
The properties of the luminal substances that are taken
up may have an impact on the subsequent immune re-
sponses. Food hypersensitivity is related to the failure of
oral tolerance, and uptake of intact antigens untreated with
digestive enzymes have been shown to promote allergy.
Moreover, intestinal administration of intact bovine serum
albumin has been shown to enhance anti–bovine serum al-
bumin responses.6,7 Indeed, the inability to digest a 33mer
gliadin peptide containing multiple immunodominant epi-
topes is a central contributor to celiac disease pathogen-
esis.8 Thus, digestion is a crucial process for nutrition, but
also for maintaining appropriate immune responses.
In contrast to the earlier-described model of nutrient
digestion and absorption, more than 50 years ago studies
identiﬁed that macromolecular substances up to the micron
range could be found in the blood after oral administration
of compounds to animals and humans.9 This phenomenon
was termed persorption, because it was believed to be
distinct from the process of nutrient absorption described
earlier.10,11 The absorbed particles were found in many
body ﬂuids, such as blood, lymph, bile, milk, and urine, and
early speculation that the passage of particulate matter
across the intestinal barrier arose from activity of the
muscularis mucosa layer potentially squeezing particulates
into epithelial cells.10,11 Although persorption has long been
observed, it has remained a relatively understudied area
and accordingly the mechanistic details and the physiologic
role of persorption remain enigmatic, with some studies
implying persorption of food substances may contribute to
disease.12–14
Pathways to Cross the Intestinal
Epithelium
Multiple pathways by which luminal substances cross
the intestinal epithelial barrier have been identiﬁed
(Figure 1). Not shown are an array of proteins facilitating
the transport of small molecules including anions, cations,
zwitterions, lipids, small-molecule drugs, and small pro-
teins.15 Although these transporters are signiﬁcant con-
tributors to gastrointestinal physiology, the molecules they
transport are generally too small to be targets for antigen-
speciﬁc T-cell responses, and are not discussed further
here. Conceptually, the simplest pathways delivering large
macromolecules across the epithelium is barrier disruption
resulting from the loss of epithelial integrity, allowing
luminal substances to come into direct contact with un-
derlying immune cells. This occurs during disease processes
such as inﬂammatory bowel disease, in which large portions
of the epithelial surface are ulcerated. However, the
contribution of barrier disruption to the delivery of luminal
substances to the immune system in the healthy intestine is
less likely. Moreover, barrier disruption is an uncontrolled
process, which would be relatively incompatible with
regulating immune responses to luminal substances in the
steady state. Indeed, in the absence of disease processes, the
translocation of whole live bacteria can occur in the absence
of barrier disruption,16–18 suggesting the existence of other
Table 1. Intestinal Microorganisms and Products Contributing to Host Immunologic, Metabolic, and Physiological Processes
Product Microbes involved Function References
Short-chain fatty acids (acetate,
propionate, and butyrate)
Clostridium, Bacteroides Energy source, immune cell regulation,
epithelial barrier integrity
72–75
Intermediate fermentation products
(succinate/lactate)
Lactic acid bacteria, Biﬁdobacteria Contribute to ﬁnal pool of short-chain
fatty acids
76,77
Microbial biotransformation of bile
acids
Bacteroides, Biﬁdobacterium, Lactobacillus Metabolic processes 78–80
Vitamin synthesis (vitamin K, biotin,
folates, riboﬂavin, and so forth)
Firmicutes, Actinobacteria, Fusobacteria Metabolic and physiological signiﬁcance 81–83
Polysaccharide A Bacteroides fragilis Immune modulator 84–87
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pathways and the lack of need to grossly compromise the
epithelial barrier to deliver luminal substances of signiﬁcant
size.
Paracellular transport involves the passage of luminal
substances through tight junctions that form the major
barrier between epithelial cells. At least 2 pathways of
paracellular transport through tight junctions exist: a high-
capacity pore allowing for the passage of small ions and
uncharged particles, and a low-capacity leak pathway
allowing for the passage of larger molecules.19 Both the pore
and leak pathway are dynamic and can be regulated by in-
ﬂammatory stimuli,20 with the pore pathway’s capacity be-
ing deﬁned by the number of pore-forming claudins
expressed in the tight junction and the leak pathway’s ca-
pacity being associated with the number of tight junction
strands present between the epithelial cells. Although these
pathways are well studied and could contribute to the de-
livery of substances to DCs underlying the epithelium, in
general the size of the substances traversing tight junctions
and pores in the healthy state would not be sufﬁcient for the
induction of antigen-speciﬁc T-cell responses that are
characteristic of tolerance in the steady state.
Microfold cells (M cells) were ﬁrst described in the
follicle-associated epithelium overlying Peyer’s patches
(PPs) and lymphoid follicles in the intestine.21 These cells
had unique morphology including a lack of microvilli, a rigid
brush border, and a reduced glycocalyx. M cells have an
apical surface with membrane microdomains facilitating
endocytosis of particulates from the lumen. The basolateral
surface of M cells is deeply invaginated to allow for a pocket
Figure 1. Pathways of speciﬁc transport mechanisms allow nutrient uptake and the delivery of macromolecules to the
immune system while maintaining the epithelial barrier. Low-molecular-weight substances leak through tight junctions
between enterocytes in paracellular leaks. Tissue resident macrophages can extend dendrites into the lumen and capture
luminal antigens. Intestinal goblet cells take up luminal antigens and deliver them to antigen-presenting cells in the lamina
propria via GAPs. M cells are specialized transcytotic cells that are located on the follicle-associated epithelium overlying
Peyer’s patches that transport soluble antigens and bacteria to antigen-presenting cells in the follicles. Nutrient uptake in-
volves enterocyte absorption of smaller molecules such as monosaccharides, lipids, and dipeptides.
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containing lymphocytes and antigen-presenting cells
(APCs). This arrangement allows for the basolateral surface
to come within microns of the apical surface, signiﬁcantly
reducing the distance that luminal substances would travel
during transcytosis. Indeed, M-cell–mediated transcytosis is
the most studied pathway delivering luminal substances
across the epithelium for the induction of adaptive immune
responses. Most studies support that M cells function to
transport luminal substances to induce IgA and T-cell re-
sponses in the PPs and lymphoid follicles. Some studies
have shown induction of tolerance by targeting antigens
directly to M cells,22 suggesting that M cells overlying PPs
are a pathway supporting steady-state, antigen-speciﬁc, T-
cell responses. In addition, enrichment of antigen-speciﬁc
Tregs have been found in PPs of orally tolerized mice.23
CD4 T cells expressing transforming growth factor-b II re-
ceptor are enriched in PPs of C57BL/6 mice after high- or
low-dose ova feeding and the majority of these express
Foxp3.24 Despite these ﬁndings, the requirement of PPs in
oral tolerance induction remains controversial. Studies us-
ing PP-null mice showed normal induction of oral tolerance,
and only the removal of MLN before tolerization could
prevent oral tolerance induction.25,26 Moreover, although
suppression of humoral immune responses to oral antigen
was impaired and associated with a reduced number of T
cells in the PPs in germ-free mice,27 antigen-speciﬁc T-cell
tolerance to oral antigens was not impaired in germ-free
mice,28 suggesting that there may not be a direct relation-
ship between events in the PPs and antigen-speciﬁc toler-
ance to luminal substances. Together, these studies suggest
that although PPs may be a site for antigen-speciﬁc toler-
ance induction to luminal substances, their role may be
secondary to MLNs in this process. In contrast to the initial
descriptions of the location of M cells, M cells also have been
observed in the villous epithelium of the small intestine,29
raising the possibility that M cells might be required for
the transcytosis of luminal macromolecules across the
non–follicle-bearing epithelium to initiate adaptive immu-
nity. Moreover, M cells could deliver luminal macromole-
cules to DCs within the PPs or lymphoid follicles, which then
migrate to distant sites to initiate adaptive immune re-
sponses. However, observations have suggested that PPs are
not required to induce oral tolerance and that T-cell re-
sponses to oral antigens can be induced in the absence of M
cells,25,26,30 thus although M cells contribute to macromo-
lecular transport and immune responses within follicles,
their requirement for macromolecular transport contrib-
uting to immune responses in the MLN and oral tolerance is
less clear.
In a landmark observation, it was identiﬁed that APCs
within the lamina propria (LP) had the ability to extend
dendrites between epithelial cells to capture bacteriawithout
compromising the epithelial barrier.31,32 Subsequent studies
using ex vivo and in vivo imaging approaches on explants and
living intestine from APC reporter mice showed LP-APC
extension of transepithelial dendrites (TEDs) in the unin-
fected intestine and increased TED extension in response to
infection,33,34 raising the possibility that the LP-APC exten-
sion of TEDs plays a role in sampling the luminal substances
in both the steady state and during infection (Figure 1). A
combination of ﬁndings describing deﬁcits in C-X3-C Motif
Chemokine Receptor 1 (CX3CR1) mice provided further
support to the concept of direct capture of luminal sub-
stances by LP-APCs to support adaptive immune responses.
CX3CR1
þ LP-APC TED extension was impaired in the absence
of CX3CR1.
35 Moreover, studies found that tolerance to a di-
etary antigen was not effectively induced in the absence of
CX3CR1.
4,36 In combination, these observations implied that
LP-APC directly capture luminal macromolecular substances
in the steady state to support adaptive immune response.
However, LP-APC TED extension was found to be absent in
some mouse strains,37 which do not show a deﬁcit in the
induction of T-cell responses to dietary antigens.4 Further-
more, the absence of CX3CR1, which impairs TED extension,
35
did not impair the stimulation of CD4þ T cells in the MLN in
response to luminal antigen.38 Together these observations
indicate that although TED extension could directly deliver
luminal substances to LP-APCs, the extension of TEDs is not
required for the induction of antigen-speciﬁc T-cell re-
sponses in the steady state. Although the extension of TEDs
may not be required for the induction of antigen-speciﬁc T-
cell responses to luminal substances in the steady state,
CX3CR1þ LP-APCs still may play a critical role in this process.
CX3CR1þ LP-APCs have been shown to capture luminal
substances and transfer them to CD103þ LP-APCs to initiate
T-cell responses to luminal substances and promote toler-
ance.36 Thus, CX3CR1þ LP-APCs may contribute to steady-
state responses to luminal substances in multiple ways.
Recently, it was identiﬁed that goblet cells can take up
luminal high-molecular-weight substances and transfer
them to LP-APCs in a process termed goblet cell–associated
antigen passages (GAPs).39 Interestingly, the endocytic
properties of intestinal goblet cells to take up luminal sub-
stances has been noted for decades,40–43 and intriguingly
this property of goblet cells is being leveraged for oral drug
delivery.44–49 Observations support that LP-APCs acquiring
luminal substances via GAPs are effective at inducing
antigen-speciﬁc T-cell responses. When goblet cells and
GAPs are absent or when GAPs are inhibited, LP-APCs
cannot acquire luminal substances in a manner capable of
stimulating antigen-speciﬁc T-cell responses in ex vivo as-
says.39,50,51 Moreover, in the absence of GAPs, adoptively
transferred T cells speciﬁc for luminal antigens do not
expand or proliferate in the draining mesenteric lymph
nodes in vivo.51,52 Thus, goblet cells and GAPs have an
essential role in delivering luminal antigens for the induc-
tion of T-cell responses outside of the organized intra-
mucosal lymphoid tissues, the PPs, and isolated lymphoid
follicles. Whether this property to take up and deliver
luminal substances to support adaptive immune responses
extends to other intestinal epithelial secretory lineages,
Paneth cells, and enteroendocrine cells has not been fully
explored. Similar to goblet cells, Paneth cells and enter-
oendocrine cell development is dependent on the tran-
scription factor mouse atonal homologue 1,53 and
accordingly would be affected by strategies deleting mouse
atonal homologue 1 in intestinal epithelial cells. Enter-
oendocrine cells have been observed to take up high
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molecular substances from the gut lumen.54 However,
because of their slower turnover, Paneth cells and enter-
oendocrine cells still are present during the time frame of
the experiments, showing that the loss of goblet cells ab-
rogates luminal antigen acquisition by LP-APCs, suggesting
that their contribution to luminal antigen delivery to LP-
APCs for the subsequent generation of T-cell responses is
limited.55,56
Regulation and Regional Differences in
GAPs to Control Immune Responses to
Luminal Substances
In the steady state, adaptive immune responses to the
diet and commensal microbes are dominated by tolerance,
which largely is mediated by Foxp3þ Tregs. Tolerance to
these innocuous antigens is necessary to avoid inappro-
priate inﬂammatory responses because these substances
are encountered in the setting of abundant inﬂammatory
stimuli from microbial products. In addition, it has been
proposed that harnessing oral tolerance can be an effective
means of treating immunopathology in type 1 diabetes,57
arthritis,58 autoimmune encephalitis,59 and other dis-
eases.60 In contrast, during enteric infection, the adaptive
immune response shifts to an inﬂammatory phenotype to
promote pathogen clearance and protective immunity.
Indeed, inﬂammatory T-cell responses can be generated
toward dietary and commensal gut microbial antigens
encountered during enteric infections,51,61 thus empha-
sizing the need to control the immune system’s access to
these innocuous antigens, which can be mediated by GAP
formation. GAPs form in response to acetylcholine acting on
the muscarinic acetylcholine receptor 4 on goblet cells.39
Observations support that acetylcholine is largely not
limiting and that GAP formation and subsequent luminal
antigen delivery to LP-APCs is largely regulated via inhibi-
tion of goblet cell responsiveness to acetylcholine.18,50–52
Whether the source of acetylcholine supporting GAP for-
mation is neuronal, non-neuronal, or can come from both
sources is unknown. The inhibition of goblet cell respon-
siveness to acetylcholine to form a GAP occurs via activation
of epidermal growth factor receptor (EGFR) expressed in
goblet cells.51 Activation of EGFR in goblet cells suppresses
the ability of goblet cells to respond to acetylcholine through
muscarinic acetylcholine receptor 4 expressed by goblet
cells to form GAPs.50,52 Thus, GAP inhibition can be medi-
ated by multiple stimuli activating the EGFR including by
luminal EGFR ligands, microbial ligands signaling via Toll-
like receptors (TLRs) and MyD88 to transactivate the
EGFR, and IL1b binding the IL1R to activate MyD88 and
transactivate the EGFR50,51 (Figure 1).
When present, GAPs throughout the gastrointestinal
tract have been observed to deliver luminal substances to
LP-APCs. However, there are regional differences in some
properties of GAPs. Although microbial sensing suppresses
colonic GAP formation, goblet cell–intrinsic MyD88-
dependent sensing of the microbiota does not suppress
GAP formation in the small intestine (SI) likely owing to the
lower level of TLR expression and higher expression of
inhibitors of TLR signaling by SI goblet cells when compared
with colonic goblet cells.50 A small number of GAPs are
present in the distal colon despite the presence of the
abundant gut microbiota.62 Whether this is owing to the
dense mucus layer in the distal colon preventing sufﬁcient
amounts of microbial products from accessing the goblet
cells to inhibit GAP formation or whether this is owing to
GAP formation via other receptors and stimuli is not known.
When present, GAPs in the proximal colon, but not in the
distal colon or SI, translocate live commensal gut bacte-
ria.18,62 The basis for this differential ability to translocate
bacteria is unknown but could be related to the relatively
less abundant bacteria in the SI lumen and the less-
penetrable mucus layer in the distal colon when compared
with the proximal colon.63
The pathways controlling GAP formation are central to
allowing the immune system to respond appropriately to
luminal substances. When GAP inhibition by goblet
cell–intrinsic microbial sensing is overridden in the prox-
imal colon, inﬂammatory responses are generated, and live
commensal bacteria translocate across the colonic epithe-
lium.18,62 Moreover, overriding GAP inhibition during
enteric infection induces inﬂammatory T-cell responses to
dietary antigens.51 Perhaps the most striking example of the
control of GAP formation occurs in the preweaning gut.
During the ﬁrst 10 days of life in nursing mice, GAPs are
inhibited by EGF, presumably of maternal origin in breast-
milk. After 10 days of life, when the luminal EGF concen-
tration decreases, GAPs form ﬁrst in the colon, then in the SI,
and then are inhibited in the colon by the gut microbiota
around the time of weaning. These orchestrated events
allow for a deﬁned interval between the 10th day of life and
weaning, at which point tolerance to some commensal
bacteria is established.52 Moreover, altering the pattern of
GAP formation preweaning has long-term effects, predis-
posing to colitis when commensal bacteria are encountered
by the immune system later in life.52 Although the role of
GAPs in inducing tolerance to dietary antigens in the steady
state has yet to be explored, these observations suggest that,
when present, GAPs facilitate tolerance to dietary and
commensal bacterial antigens and that GAP inhibition helps
prevent inappropriate responses to dietary and commensal
bacterial antigens encountered in hostile settings.
A Potential Link Between Gaps and
Early Observations of Macromolecular
Transport of Luminal Substances
Two phenomena of transport of macromolecular luminal
substances were described decades ago, persorption,14,64,65
which occurs in the adult intestine, and macromolecular
transport in the neonatal intestine, which persists for a
deﬁned period, the cessation of which has been termed
closure.66–68 It is interesting to speculate how these earlier
observations might relate to the more recent descriptions of
goblet cell–mediated transport of macromolecular
substances.
Studies have suggested that persorption occurs by
engulfment of luminal macromolecules by columnar villous
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epithelial cells, and based on morphologic appearance these
epithelial cells may be undergoing apoptosis.69,70 Whether
these columnar epithelial cells included goblet cells or were
restricted to goblet cells was not determined. However,
although earlier studies suggested an association of
apoptosis with persorption by morphologic appearance,
GAP formation was not associated with goblet cell apoptosis
as determined by immunoﬂuorescence staining.39 In addi-
tion, it has been observed that persorption was increased by
antibody coating, suggesting that although this process may
not require antibody coating, it may be facilitated by frag-
ment crystallizable region (Fc)-receptor binding,71 a process
that has not been evaluated in antigen delivery by GAPs. In
support of a link between persorption and GAP formation,
persorption was inhibited by the panmuscarinic receptor
agonist atropine and further induced by the acetylcholin-
esterase inhibitor prostigmine,65 which increases acetyl-
choline levels. Thus, identical stimuli induce persorption
and GAPs, potentially suggesting that the historical obser-
vations of persorption may have included macromolecular
delivery by GAPs.
In the 1970s, studies documented the ability of neonatal
gut of many mammalian species in uptake of globulins from
maternal colostrum, which was believed to be essential for
passive immunization. The phenomenon of macromolecular
transport in the neonatal period is a property that largely
has been attributed to the SI. This may be owing in part to
the presence of vacuolated fetal enterocytes in the pre-
weaning SI, which have the capacity to endocytose large
quantities of macromolecules from milk.66 However,
whether the vacuolated fetal enterocytes in the SI transport
the endocytosed substances across the epithelium for
release to DCs underlying the epithelium has not been
evaluated, and is at odds with observations that the LP-APCs
in the SI cannot be loaded with luminal antigens in the
neonatal period in mice.52 Alternatively, if the macromo-
lecular transport seen in the preweaning gut occurs in the
colon, this could be consistent with the presence of colonic
GAPs during a deﬁned preweaning interval. Potentially in
support of a link between the presence of colonic GAPs in a
deﬁned preweaning interval and increased intestinal
permeability in the neonatal gut, in some mammals, closure
occurs around the time of weaning, the time in which
colonic GAPs become inhibited by the expanding gut
microbiota, and closure is altered by artiﬁcial feeds,67,68
which should alter colonic GAPs in the preweaning intestine.
Conclusions
To combat the danger of invasion by potential pathogens
yet allow selective sampling of the luminal contents to
promote immune homeostasis, mechanisms exist to control
and maintain the epithelium as a selective barrier to the
uptake of macromolecular antigens. Although multiple
pathways exist by which substances can cross the epithe-
lium, steady-state encounters by the immune system with
luminal substances in a manner capable of inducing antigen-
speciﬁc T-cell responses are dominated by GAP-mediated
antigen delivery. It is intriguing to note that observations
of the endocytic property of goblet cells and macromolec-
ular transport in the gut foreshadowed identiﬁcation of
goblet cell–mediated antigen delivery by decades. Although
much remains to be learned about this antigen delivery
mechanism, observations support that it is highly regulated
and central to gut immune homeostasis. During the past
decade, signiﬁcant progress has been made in our under-
standing of macromolecular transport across the intestinal
epithelium. Although our knowledge of intestinal transport
has increased, we lack an understanding of how these
processes are altered by disease and by gut microbiota, and
whether alterations in these processes contribute to disease
pathogenesis.
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